D01.2
Carcinoma in situ of rectum
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ of the rectum, classified under ICD-10 code D01.2, is a non-invasive form of cancer located in the rectum's inner lining. Unlike invasive rectal cancers, carcinoma in situ is confined to the epithelial layer and has not yet penetrated deeper tissues or spread beyond the rectal wall. Early detection and appropriate management are vital to prevent progression to invasive disease. This condition typically affects adults and may present with specific symptoms or be found incidentally during examinations for other concerns.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting cell growth and division Chronic inflammation of the rectal mucosa Lifestyle factors such as a diet high in processed or red meat and low in fiber Smoking and alcohol consumption Previous or concurrent colorectal neoplasms Personal or family history of colorectal cancer or precancerous lesions
Key Symptoms: Rectal bleeding or spotting Persistent rectal discomfort or pain Changes in bowel habits, such as diarrhea or constipation A feeling of incomplete bowel evacuation Anemia due to chronic blood loss Unexplained weight loss or fatigue in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of carcinoma in situ of the rectum involves several procedures to accurately identify and assess the lesion. These include: - **Digital Rectal Examination:** A physical exam to detect irregularities or lumps. - **Endoscopy (Sigmoidoscopy or Colonoscopy):** Provides direct visualization of the rectal mucosa and allows tissue biopsy. - **Biopsy:** Microscopic examination of tissue samples to confirm carcinoma in situ. - **Imaging Studies:** Pelvic MRI or endorectal ultrasound may be used to evaluate the extent of the lesion and check for deeper invasion or nearby lymph nodes. - **Histopathological Analysis:** Assesses cellular details to confirm non-invasive nature and rule out invasive carcinoma.
Treatment Protocols: Management of carcinoma in situ of the rectum involves strategies aimed at complete removal of the abnormal tissue and monitoring for recurrence or progression. Typical treatments encompass: - **Endoscopic Resection:** Techniques such as polypectomy or endoscopic mucosal resection (EMR) to excise superficial lesions. - **Surgical Intervention:** In cases where endoscopic removal isn't feasible or if there’s suspicion of invasion, minimally invasive surgery such as local excision or more extensive procedures may be recommended. - **Surveillance:** Regular follow-up with endoscopy to monitor for new or recurrent lesions. - **Lifestyle and Dietary Modifications:** To reduce risk factors and support overall colorectal health. In some instances, additional treatments like topical therapies or chemopreventive agents may be explored, depending on individual case specifics and physician recommendations.
Clinical Advice & FAQs
Billing Guidance
Is D01.2 a billable ICD-10 code?
Yes, D01.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D01.2?
Clinical documentation must specify the nature of Carcinoma in situ of rectum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
